Pavel Mirovský, M.D., Ph.D., MBA, is a medical doctor with a long-term pharmaceutical business career. He became President of Europe and General Manager of Europe at Valeant Pharmaceuticals, upon its acquisition of PharmaSwiss. Prior to joining PharmaSwiss, he served as regional General Manager at IMS for CEE, Near East/ Middle East, North Africa, Benelux, Nordics and Portugal. He also served as President and CEO of Polpharma and led Aventis' operations in MENA and CEE.
Dr. Mirovský worked as an expert for the World Health Organization in Africa and as a visiting scientist at Harvard Medical School. He obtained his M.D., Ph.D, and Associate Professor degree from the Charles University in Prague and an MBA from the IFTG Prague. After graduation, he served in several positions at the Czech Academy of Sciences.